Like Clintara

announced 6/22/2015 via PR Newswire

Clintara will be merged with Bracket Global,

synopsis: Bracket Global, LLC and Clintara have agreed to combine. Bracket will integrate the Clintara platform of surveillance strategies developed for clinical trials within Bracket's proprietary electronic platform for Clinical Outcome Assessments (eCOA). Clintara is a privately-held clinical service and technology company headquartered in Boston, MA.
buyer parent: Parthenon Capital Partners
buyer: Bracket Global
Bracket is a specialty services provider dedicated to helping pharmaceutical sponsors and contract research organizations (CROs) achieve greater certainty and accurate outcomes in their clinical trials. "
target: Clintara
Clintara is a privately-held clinical service and technology company headquartered in Boston, MA. Clintara was founded in 2009 by Dr. Steven Targum, MD. Clintara has conducted over 60 trials which have included 23,000 screens at over 2,200 sites around the world.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 1/11/2021 via Yahoo, Inc.

RxE2, will acquire Habitu Health

synopsis: RxE2, which is bringing the practice of pharmacy to clinical research, has agreed to acquire Habitu, an Israeli-based technology company. Habitu focuses on people's habits and behaviors to create a KyP (know your patient) engine enabled by artificial intelligence, improving patient outcomes.
buyer: RxE2
RxE2 is the first company to make decentralized clinical trials a cost-effective reality. By integrating the practice of pharmacy into every aspect of clinical trials, RxE2 empowers local pharmacists to make clinical trials more accessible to patients, everywhere. "
target: Habitu Health
Habitu focuses on people's habits and behaviors to create a KyP (know your patient) engine enabled by artificial intelligence, improving patient outcomes by providing real-time analyses of a more comprehensive set of patient data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 9/6/2019 via BNC Analysis

Advarra, will acquire Forte Research Systems

synopsis: Advarra, the premier provider of institutional review board, institutional biosafety committee, and research quality and compliance consulting services, will acquire Forte, the industry's leading provider of standards-based clinical research technology solutions for major academic medical centers, cancer centers, and health systems.
buyer parent: Genstar Capital LLC
buyer: Advarra
Advarra, headquartered in Columbia, Md., provides institutional review board (IRB), institutional biosafety committee (IBC) and global research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers and investigators. "
target parent: Primus
target: Forte Research Systems
Forte provides software and services in the critical areas of clinical trial management, clinical data management, and research administration for cancer centers, academic medical centers, and health systems. Forte's flagship Clinical Trial Management System, OnCore manages clinical research data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/17/2019 via GlobeNewswire

Anju Software, will acquire OmniComm Systems, Inc.

synopsis: Anju Software, a leading provider of comprehensive software solutions to the life sciences industry, will be acquiring OmniComm, a healthcare technology company that provides web-based electronic data capture and eClinical solutions and related value-added services.
buyer parent: ABRY Partners, LLC
buyer: Anju Software
Anju Software, Inc. is a leading provider of comprehensive software solutions to the life sciences industry that provides an integrated platform spanning clinical operations, medical affairs, and commercial divisions, including integrated data intelligence. "
target: OmniComm Systems, Inc. (OTCPK:OMCM:$14,891.70)
OmniComm is a healthcare technology company that provides web-based electronic data capture and eClinical solutions and related value-added services to pharmaceutical and biotech companies, contract research organizations, and other clinical trial sponsors.
price ($mm)[EV]
$72 [$81]
rev ($mm)
$25
EBITDA ($mm)
$2
EV / rev
3.4x
EV / EBITDA
46.2x
closed 1/27/2015 via PR Newswire

genae, acquired e-novex

synopsis: genae, a global Contract Research Organization (CRO) and services provider for the medical industries, announced the acquisition of e-novex, a leading provider of electronic data tools that change medical research. e-novex' proprietory Electronic Data Capture (EDC) technology is widely adopted by various types of medical research organizations.
buyer: genae
genae is involved in the development and commercialization of medical devices, biologics and therapies that change medical practice. As a full service CRO and innovative services provider for the medical industries, genae aims at improving health and quality of life. "
target: e-novex
e-novex is a certified web technology company that provides electronic data tools that facilitates medical research. e-capture.net is an intuitive and user-centric EDC platform that features easy data entry, complex validation rules and flexible reporting.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/9/2012 via PR Newswire

ERT, acquired invivodata, Inc.

synopsis: ERT, a global technology-driven provider of health outcomes services to biopharmaceutical sponsors and contract research organizations (CROs), announced the acquisition of invivodata, Inc, a leading provider of electronic Patient Reported Outcomes (ePRO) solutions and Consulting services, based in Pittsburgh, PA.
buyer parent: Genstar Capital LLC
buyer: ERT
ERT is a global technology-driven provider of health outcomes research services and customizable medical devices supporting biopharmaceutical sponsors and contract research organizations to achieve their drug development and healthcare objectives. "
target: invivodata, Inc.
invivodata is a fully-integrated Clinical Outcome Assessments organization delivering regulatory-proven strategic consulting and practical electronic solutions to biopharmaceutical companies who depend upon patient-centered research.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 11/17/2017 via BNC Analysis

Roche Ltd, will acquire Viewics, Inc.

synopsis: Roche announced an agreement with Viewics, Inc., a privately held software company focused on laboratory business analytics. The Viewics solution allows for efficient integration of big data from a variety of IT systems in the laboratory and beyond, pioneering a new way in extracting, cleansing, transforming and augmenting data.
buyer: Roche Ltd
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare. "
target: Viewics, Inc.
California-based Viewics Inc. is a software company that focuses on laboratory business analytics. The Viewics solution allows for efficient integration of big data from a variety of IT systems in the laboratory and beyond.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/1/2015 via PR Newswire

Elsevier B.V., acquired InferMed

synopsis: Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced the acquisition of InferMed, a London-based clinical decision support (CDS) technology company.
buyer parent: RELX Group plc
buyer: Elsevier B.V.
Elsevier is a provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. "
target: InferMed
Formed in 1999 InferMed has become a global leader in providing software and services to the healthcare, pharmaceutical, and clinical research sectors with whom they work in close collaboration.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/10/2021 via PR Newswire

Advarra, acquired Bio-Optronics Group, LLC

synopsis: Advarra, the market leader in regulatory review solutions and clinical site technologies, has acquired Bio-Optronics, a leading healthcare information technology company. Bio-Optronics offers software solutions for clinical research management, staff scheduling, and patient workflows.
buyer parent: Genstar Capital LLC
buyer: Advarra
Advarra, headquartered in Columbia, Md., provides institutional review board (IRB), institutional biosafety committee (IBC) and global research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers and investigators. "
target: Bio-Optronics Group, LLC
Bio-Optronics is a leading healthcare information technology company. Bio-Optronics helps healthcare professionals to enhance quality, productivity, patient and staff satisfaction. They offer software solutions for clinical research management, staff scheduling, and patient workflows.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 2/19/2021 via PR Newswire

MindMed, will acquire HealthMode

synopsis: MindMed, a leading psychedelic medicine biotech company, will acquire HealthMode, a digital medicine and therapeutics startup that uses Artificial Intelligence (AI)-enabled digital measurement to increase the precision and speed of clinical research and patient monitoring.
buyer: MindMed (OTCPK:MMED.F:$0.00)
MindMed is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances. "
target: HealthMode
HealthMode drives progression to next-generation clinical trials by developing and delivering AI-enabled digital measurement methods for clinical trials. Its measurement techniques streamline and provide assurance for screening and eligibility, provide early detection of adverse events, and more.
price ($mm)
$33
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/4/2020 via BusinessWire

GI Partners, acquired Clinical Ink

synopsis: Clinical Ink, a global clinical trial technology company, announced its acquisition by GI Partners, a leading private equity investment firm. Clinical Ink's service-first methodology and dedication to supporting a wide range of deployment options enable confident decisions, faster, and have driven meaningful industry adoption.
buyer: GI Partners
GI Partners is a private investment firm based in San Francisco. The firm has raised over $20 billion in capital from leading institutional around the world to invest in private equity, real estate, and data infrastructure strategies. "
target parent: NovaQuest
target: Clinical Ink
Clinical Ink is a global clinical technology company. Their service-first methodology and dedication to supporting a wide range of deployment options enable confident decisions, faster, and have driven meaningful industry adoption.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/15/2018 via Company Press Release

NovaQuest, acquired Clinical Ink

synopsis: Clinical Ink, the pioneering provider of eSource and next-generation ePRO/eCOA solutions for clinical development, announced that the private equity team at NovaQuest Capital Management has acquired a majority of the outstanding shares of the company from existing investors and provided a substantial infusion of additional growth capital.
buyer: NovaQuest
NovaQuest Capital Management is a leading investor in life sciences and healthcare through their BioPharma and Private Equity strategies. NovaQuest Capital Management manages over $1.6 billion through two platforms: BioPharma and Private Equity. "
target: Clinical Ink
Clinical Ink provides eSource solutions for the clinical trials industry. It offers SureSource, an electronic source solution that allows users to record comments, explanations, and validated source data on protocol specific eSource documents, as well as captures the data required by the protocol.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/6/2018 via PR Newswire

CareMetx, acquired VirMedica

synopsis: CareMetx, LLC, a technology-enabled hub services provider for pharmaceutical and biotechnology manufacturers, announced they have acquired VirMedica, the leader in e-access technology solutions designed to streamline patient access to life-enhancing therapies.
buyer parent: The Vistria Group
buyer: CareMetx
CareMetx serves pharmaceutical, biotechnology and device manufacturers with technology and specialty hub services to support the patient journey. CareMetx is committed to delivering compassionate care to patients and decisionmaking data and confidence-building insight to manufacturer-clients. "
target: VirMedica
VirMedica is a leading provider of technology solutions that connects stakeholders, automates workflows and delivers benefits information in real-time. Virmedica is designed to optimize the commercialization of specialty pharmaceutical products.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/3/2020 via PR Newswire

InsightfulScience, acquired Statsols

synopsis: Insightful Science has acquired Statsols, the developer of nQuery, the world's most trusted clinical trial design platform. nQuery is the software of choice for researchers who want to calculate sample size and power to optimize their clinical trial designs. It is proven to make clinical trials faster, less costly, and more successful.
buyer: InsightfulScience
Insightful Science is a technology company with category-leading software designed to empower scientists at every step of the research and development process. "
target: Statsols
Statsols is the provider of nQuery, the complete trial design platform to make clinical trials faster, less costly, and more successful. nQuery is used to optimize clinical trial design in the largest biopharma companies, contract research organizations and research institutions worldwide.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/19/2020 via Company Press Release

Inmar Inc., acquired RXTransparent

synopsis: Inmar has announced that it has acquired Forerunner Holdings Inc., the developers of RXTransparent, an SAAS platform allowing healthcare providers to put their finger on the pulse of drug supply chain through product inventory transparency, regulatory compliance and supply chain analytics.
buyer parent: OMERS Private Equity
buyer: Inmar Inc.
Inmar’s holistic portfolio of media products enables advertisers to access a variety of intelligent tools, including its influencer media platform, conversational commerce (chat-based media), audience extension and on-site digital media for retail. "
target: RXTransparent
Forerunner Holdings Inc. are the developers of RXTransparent, an SAAS platform allowing healthcare providers to put their finger on the pulse of drug supply chain through product inventory transparency, regulatory compliance and supply chain analytics.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/7/2019 via GlobeNewswire

Tabula Rasa Healthcare, acquired DoseMe

synopsis: Tabula Rasa HealthCare, Inc., a healthcare technology company advancing the field of medication safety, has acquired DoseMe. DoseMe is the developer of DoseMeRx, an advanced precision dosing tool to help physicians and pharmacists accurately dose patients’ high-risk parenteral medications. DoseMe is based in the US and Australia.
buyer: Tabula Rasa Healthcare (TRHC:$204.27)
Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize patient outcomes, lower healthcare costs and improve organizational performance. "
target: DoseMe
DoseMe is the developer of DoseMeRx, an advanced precision dosing tool to help physicians and pharmacists accurately dose patients’ high-risk parenteral medications based on individual needs, resulting in significant improvements to mortality, risk, and patient outcomes.
price ($mm)
$21
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/4/2016 via BusinessWire

Rx30 Pharmacy System, acquired vMEDEX, Inc.

synopsis: Transaction Data Systems, Inc., doing business as Rx30, announced that Rx30 has completed its acquisition of vMEDEX. vMEDEX has been a valued integration partner over the past 3 years, demonstrating an innovative approach to providing advanced clinical services functionality.
buyer: Rx30 Pharmacy System
Rx30 is a total Pharmacy Management Software application that truly acts as the hub for all pharmacy management activities, including prescription dispensing, fully automated refills and reminders, workflow management, adherence management, document management, smart phone/web refills and more. "
target: vMEDEX, Inc.
vMEDEX is a healthcare Software as a Service company. Healthcare practitioners are able to care for more patients with greater quality and consistency using vMEDEX powered solutions. vMEDEX deliver expert healthcare assistance when and where it is needed most to protect those most vulnerable.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/20/2013 via BusinessWire

First DataBank, Inc., acquired Design Clinicals

synopsis: First Databank, the leading provider of clinical drug knowledge that helps improve medication-related decisions and patient outcomes, announced that an affiliate of FDB has acquired Design Clinicals, a healthcare IT company dedicated to providing clinician-friendly solutions for improving medication reconciliation and the delivery of patient care.
buyer parent: The Hearst Corporation
buyer: First DataBank, Inc.
First DataBank Inc. provides the healthcare industry with the most comprehensive, accurate and timely drug, medical, and nutrition information for integration into healthcare information systems. "
target: Design Clinicals
Design Clinicals, Inc. is a healthcare information technology company dedicated to providing leading-edge tools to improve the delivery of patient care. Design Clinicals offers software that enhances communication, workflow, and patient safety.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/5/2020 via Company Press Release

Clanwilliam Group Ltd., acquired KM Medical Software

synopsis: Clanwilliam Group, a global family of businesses committed to healthcare, technology and services, has acquired KM Medical Software, an Irish company that specialises in cloud-based EMR solutions. KM Medical's iMedDoc solution allows users to access their patient records at anytime and anywhere using a desktop or mobile device.
buyer parent: Global Growth
buyer: Clanwilliam Group Ltd.
Clanwilliam Group, headquartered in Dublin, is an expanding healthcare, technology and services business. They develop, sell and integrate a range of technology solutions and services predominately to the GP, Private Consultant and pharmacy communities. "
target: KM Medical Software
KM Medical Software is an Irish company that specialises in cloud-based EMR solutions for surgeons, physiotherapists and other specialists. KM Medical's iMedDoc solution allows users to access their patient records at anytime and anywhere using a desktop or mobile device.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/11/2018 via Company Press Release

Genpact Ltd, will acquire Commonwealth Informatics Inc.

synopsis: Genpact, a professional services firm focused on delivering digital transformation, announced that it has signed a definitive agreement to acquire Commonwealth Informatics, Inc. (CI), a market-leading provider of cloud-based drug safety analytics products and services for medical research and healthcare delivery headquartered near Boston, Mass.
buyer: Genpact Ltd (G:$3,699.55)
Genpact is a global professional services firm that makes business transformation real. They drive digital-led innovation and digitally-enabled intelligent operations for their clients. They think with design, dream in digital, and solve problems with data and analytics. "
target: Commonwealth Informatics Inc.
Commonwealth Informatics provides cloud-based drug safety analytics products and services for medical research and healthcare delivery. Their Commonwealth Vigilance Workbench consists of integrated modules used by pharmaceutical and biotech companies, government agencies, and healthcare providers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/22/2015 via PR Newswire

Clintara will be merged with Bracket Global,

synopsis: Bracket Global, LLC and Clintara have agreed to combine. Bracket will integrate the Clintara platform of surveillance strategies developed for clinical trials within Bracket's proprietary electronic platform for Clinical Outcome Assessments (eCOA). Clintara is a privately-held clinical service and technology company headquartered in Boston, MA.
buyer parent: Parthenon Capital Partners
buyer: Bracket Global
Bracket is a specialty services provider dedicated to helping pharmaceutical sponsors and contract research organizations (CROs) achieve greater certainty and accurate outcomes in their clinical trials. "
target: Clintara
Clintara is a privately-held clinical service and technology company headquartered in Boston, MA. Clintara was founded in 2009 by Dr. Steven Targum, MD. Clintara has conducted over 60 trials which have included 23,000 screens at over 2,200 sites around the world.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/1/2020 via PR Newswire

Signant Health, acquired VirTrial

synopsis: Signant Health has acquired VirTrial, a provider of software solutions for remote site startup and decentralized clinical trial conduct. With the acquisition, Signant Health expands its software stack to further digitally enhance trial sites and offer sponsors superior evidence generation across traditional, decentralized, and hybrid trial models.
buyer parent: Genstar Capital LLC
buyer: Signant Health
Signant Health is the evidence generation company. Signant is focused on leveraging software, deep therapeutic and scientific knowledge, and operational expertise to consistently generate quality evidence for clinical studies across traditional, virtual, and hybrid trial models. "
target parent: Kinderhook Industries
target: VirTrial
VirTrial's virtual care platform enables pharmaceutical companies and Contract Research Organizations to empower their preferred clinical research sites to perform virtual visits through a combination of secure video, audio, chat, and messaging, which can be used on any device.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/24/2017 via PR Newswire

Bracket Global, acquired mProve Health

synopsis: Bracket, a leading clinical trial technology and specialty services provider, announced the strategic acquisition of mProve Health Inc., a leading provider of mobile technologies for life science companies. mProve Health offers regulatory compliant mobile solutions for patient recruitment and electronic clinical outcome assessments.
buyer parent: Genstar Capital LLC
buyer: Bracket Global
Bracket is a clinical trial technology and specialty services provider dedicated to helping biopharmaceutical sponsors and contract research organizations increase the power of their clinical research data by leveraging core competencies in Science, Technology, and Service. "
target: mProve Health
mProve Health is a leading provider of mobile technologies for life science companies, helping them connect better with patients. The company offers industry-grade, regulatory compliant mobile solutions for patient recruitment, patient engagement, and electronic clinical outcome assessments.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/28/2017 via PR Newswire

Genstar Capital LLC, acquired Bracket Global

synopsis: Genstar Capital, a middle-market private equity firm focused on investments in targeted segments of the healthcare, financial services, software, and industrial technology industries, announced that it has acquired Bracket, a leading scientifically-driven clinical trial technology and specialty services provider, from Parthenon Capital Partners.
buyer: Genstar Capital LLC
Genstar Capital is a San Francisco-based private equity firm that invests in leading middle-market companies. For over 20 years, they have utilized their deep industry knowledge and extensive executive networks to create value at their companies. "
target parent: Parthenon Capital Partners
target: Bracket Global
Bracket is a specialty services provider dedicated to helping pharmaceutical sponsors and contract research organizations (CROs) achieve greater certainty and accurate outcomes in their clinical trials.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/17/2016 via PR Newswire

Bracket Global, acquired CLINapps

synopsis: Bracket, a leading clinical trial technology and specialty services provider, announced the strategic acquisition of CLINapps Inc., an international software development and consulting firm that offers a comprehensive supply chain management product suite, designed to meet the unique requirements of biopharmaceuticals management.
buyer parent: Parthenon Capital Partners
buyer: Bracket Global
Bracket is a specialty services provider dedicated to helping pharmaceutical sponsors and contract research organizations (CROs) achieve greater certainty and accurate outcomes in their clinical trials. "
target: CLINapps
Established in 1999 with international offices, CLINapps is a fast-growing software development and consulting firm, creating state-of-the-art systems for the pharmaceutical and biotechnology industries.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/22/2015 via PR Newswire

Clintara will be merged with Bracket Global,

synopsis: Bracket Global, LLC and Clintara have agreed to combine. Bracket will integrate the Clintara platform of surveillance strategies developed for clinical trials within Bracket's proprietary electronic platform for Clinical Outcome Assessments (eCOA). Clintara is a privately-held clinical service and technology company headquartered in Boston, MA.
buyer parent: Parthenon Capital Partners
buyer: Bracket Global
Bracket is a specialty services provider dedicated to helping pharmaceutical sponsors and contract research organizations (CROs) achieve greater certainty and accurate outcomes in their clinical trials. "
target: Clintara
Clintara is a privately-held clinical service and technology company headquartered in Boston, MA. Clintara was founded in 2009 by Dr. Steven Targum, MD. Clintara has conducted over 60 trials which have included 23,000 screens at over 2,200 sites around the world.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/15/2013 via Market Watch

Parthenon Capital Partners, acquired Bracket

synopsis: Bracket announced that it has been acquired by Parthenon Capital Partners. Bracket partners with sponsors and contract research organizations to achieve greater certainty and accurate outcomes in their clinical trials by providing a combination of scientific, technological and operational support, from Phase I to post approval.
buyer: Parthenon Capital Partners
Parthenon Capital Partners is a leading mid-market private equity firm that utilizes niche industry expertise and a deep execution team to invest in growth companies in service industries. Parthenon seeks to be an active and aligned partner to management. "
target: Bracket
Bracket is a specialty services provider dedicated to helping pharmaceutical sponsors and contract research organizations (CROs) achieve greater certainty and accurate outcomes in their clinical trials.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/22/2015 via PR Newswire

Clintara will be merged with Bracket Global,

synopsis: Bracket Global, LLC and Clintara have agreed to combine. Bracket will integrate the Clintara platform of surveillance strategies developed for clinical trials within Bracket's proprietary electronic platform for Clinical Outcome Assessments (eCOA). Clintara is a privately-held clinical service and technology company headquartered in Boston, MA.
buyer parent: Parthenon Capital Partners
buyer: Bracket Global
Bracket is a specialty services provider dedicated to helping pharmaceutical sponsors and contract research organizations (CROs) achieve greater certainty and accurate outcomes in their clinical trials. "
target: Clintara
Clintara is a privately-held clinical service and technology company headquartered in Boston, MA. Clintara was founded in 2009 by Dr. Steven Targum, MD. Clintara has conducted over 60 trials which have included 23,000 screens at over 2,200 sites around the world.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/30/2021 via BNC Analysis

CSAM Health AS, acquired MedSciNet

synopsis: CSAM Health Group AS, the leading provider of niche eHealth solutions in the Nordics, announced that they have acquired MedSciNet AB, a provider of benchmark eHealth solutions within clinical research.
buyer: CSAM Health AS (OB:CSAM:$30.36)
CSAM is a leading Norwegian company in the specialized eHealth market with a unique blend of best in class innovative technology, and outstanding human skills. Their diverse portfolio of software solutions enables healthcare providers to access relevant clinical information at the point of care. "
target: MedSciNet
MedSciNet is a Stockholm based company specialising in design and development of web applications and on-line database systems for clinical trials and studies, quality registries, medical bio-banks, and other solutions within the medical field.
price ($mm)
$2.88
rev ($mm)
$2
EBITDA ($mm)
EV / rev
1.7x
EV / EBITDA
announced 5/27/2021 via PR Newswire

Thoma Bravo, LLC, will acquire Greenphire, Inc

synopsis: Thoma Bravo, a leading private equity investment firm focused on the software and technology-enabled services sector, has reached an agreement to acquire Greenphire, the global leader in financial lifecycle management software for clinical trials, from The Riverside Company.
buyer: Thoma Bravo, LLC
Thoma Bravo is a leading private equity firm focused on the software and technology-enabled services sectors. Thoma Bravo partners with a company’s management team to implement operating best practices, invest in growth initiatives and make acquisitions intended to accelerate revenue and earnings. "
target parent: The Riverside Company
target: Greenphire, Inc
Greenphire is the leader in global clinical trial financial process automation. Greenphire's best-in-class solutions optimize clinical trial performance by streamlining payment and logistical workflows from sponsors and CROs to sites and patients.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 4/1/2021 via BNC Analysis

DigiHealth Technologies LLP, will acquire Pharmarack Technologies Private Limited

synopsis: DigiHealth Technologies LLP will acquire 100 per cent stake in Pharmarack Technologies Pvt Ltd. Pharmarack operates a digital platform aimed at integrating and solving problems across the pharmaceutical supply chain. Pharmarack is India’s largest integrated B2B healthcare tech platform.
buyer: DigiHealth Technologies LLP
DigiHealth, based in India, is an all-in-one mobile app for pharmacy needs. The mobile app provides benefits and enables the users to order medicines online from their local pharmacy, book diagnostic lab tests, and set up automatic refills. "
target: Pharmarack Technologies Private Limited
Pharmarack, based in India, operates a digital platform aimed at integrating and solving problems across the pharmaceutical supply chain. Pharmarack is India’s largest integrated B2B healthcare tech platform – offering SaaS Solutions, Delivery Enablement, Financing Solutions, and more.
price ($mm)
$15*
rev ($mm)
$0
EBITDA ($mm)
EV / rev
298.6x
EV / EBITDA
closed 1/19/2021 via GlobeNewswire

Scarritt Group Inc., acquired TrialTech Medical Inc.

synopsis: Scarritt Group Inc., a technology-enabled leader in the planning and execution of meetings for Investigators and Coordinators of clinical trials, has acquired TrialTech Medical Inc, a leader in the application of cloud- based software and artificial intelligence enabled digital marketing for the recruitment of eligible subjects for clinical trials.
buyer: Scarritt Group Inc.
Scarritt Group is a technology-enabled, full service meeting planning and logistics company specializing in delivering clinical trial meetings worldwide. "
target: TrialTech Medical Inc.
TrialTech Medical is a software and services company supporting the pharmaceutical, biotechnology and medical device industries. They work in coordination with their clients' medical and clinical operations teams to optimize the process of clinical trial planning, recruitment and enrollment.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/19/2020 via Company Press Release

Capvis Equity, will acquire BSI Business Systems Integration

synopsis: Capvis AG, a leading private equity firm in Switzerland, will acquire a majority stake in BSI Business Systems Integration AG, a Swiss customer relationship management (CRM) software solution provider. BSI offers an omnichannel CRM and marketing automation platform that helps businesses to better support their customers.
buyer: Capvis Equity
Capvis is the leading private equity firm in Switzerland and a top player in German-speaking Europe. Capvis invests in well-positioned midsize firms with headquarters in Switzerland, Germany or Austria, typically as part of succession solutions and corporate spin-offs. "
target: BSI Business Systems Integration
Business Systems Integration (BSI) is a Swiss customer relationship management (CRM) software solution provider. BSI offers an omnichannel CRM and marketing automation platform that helps businesses to better support their customers. BIS also offers a clinical trial management software solution.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 4/10/2020 via BNC Analysis

Antares Vision, will acquire TradeTicity

synopsis: Antares Vision, the worldwide leading supplier of inspection and serialization systems for the pharmaceutical industry, will acquire an 82.83% stake in TradeTicity, a Croatian provider of serialization solutions for pharmaceutical companies. TradeTicity's CureSync is a cloud-based software solution that simplifies the serialization process.
buyer: Antares Vision (BIT:AV:$147.74)
Antares Vision is the worldwide leading supplier of inspection and serialization systems for the pharmaceutical industry. Antares Vision designs and produces the most advanced Inspection, Track & Trace and Smart Data Management solutions on the market completely tailored to individual product needs."
target: TradeTicity
TradeTicity is a Croatian provider of serialization solutions for pharmaceutical companies. TradeTicity's CureSync is a cloud-based software solution that simplifies the serialization process. CureSync covers all levels of serialization and handles billions of serialization codes.
price ($mm)
$1.12*
rev ($mm)
$1
EBITDA ($mm)
EV / rev
1.3x
EV / EBITDA
closed 11/20/2019 via BNC Analysis

Monterro, acquired Viedoc

synopsis: Monterro, the leading B2B software investor in the Nordics, has acquired a majority stake in Viedoc, a modern and sophisticated electronic data capture (EDC) system. Viedoc enables researchers to gather and evaluate clinical trial data more efficiently.
buyer: Monterro
Sweden-based Monterro is the leading B2B software investor in the Nordics, with a mission to turn software companies into market leaders. With operational experience from successfully developing and running companies, Monterro actively supports its portfolio companies in all aspects of growth. "
target: Viedoc
Viedoc is a modern and sophisticated electronic data capture (EDC) system. Viedoc enables researchers to gather and evaluate clinical trial data more efficiently. Their powerful EDC system has been used in over 2000 trials in more than 75 countries in all therapeutic areas and clinical phases.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/24/2019 via BNC Analysis

TrialScope, acquired Clinical Trial Connect, LLC

synopsis: TrialScope has acquired Clinical Trial Connect, a platform used by disease foundations and advocacy groups that connects their community members to relevant clinical trials. As part of the acquisition, founder Mike Wenger will share his technological expertise as part of the TrialScope team.
buyer: TrialScope
TrialScope is the global leader in clinical trial transparency and compliance. TrialScope's tools and systems enable their customers to improve their clinical trial process, mitigate registry and lifecycle risk, and ultimately achieve greater business success. "
target: Clinical Trial Connect, LLC
Clinical Trial Connect is a platform used by disease foundations and advocacy groups that connects their community members to relevant clinical trials. Clinical Trial Connect was founded by Mike Wenger, who developed his own algorithm for matching patients to clinical trials.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/28/2019 via BNC Analysis

JLL Partners, Water Street Healthcare Partners, acquired THREAD Research

synopsis: Water Street Healthcare Partners and JLL Partners have acquired Orange County, California-based THREAD, a provider of technology that enables virtual research approaches to modernize clinical studies and registries.
buyer: JLL Partners
buyer: Water Street Healthcare Partners
JLL Partners is a middle-market private equity firm with a 30-year track record of building and transforming businesses. Water Street is a strategic investor focused exclusively on healthcare. The firm has a strong record of building market-leading companies across key growth sectors in healthcare. "
target: THREAD Research
THREAD is a virtual research platform used by biopharma, CROs, non-profit researchers, and life science organizations to capture global clinical study data in between, as well as during and instead of clinic visits.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/17/2019 via GlobeNewswire

Anju Software, will acquire OmniComm Systems, Inc.

synopsis: Anju Software, a leading provider of comprehensive software solutions to the life sciences industry, will be acquiring OmniComm, a healthcare technology company that provides web-based electronic data capture and eClinical solutions and related value-added services.
buyer parent: ABRY Partners, LLC
buyer: Anju Software
Anju Software, Inc. is a leading provider of comprehensive software solutions to the life sciences industry that provides an integrated platform spanning clinical operations, medical affairs, and commercial divisions, including integrated data intelligence. "
target: OmniComm Systems, Inc. (OTCPK:OMCM:$14,891.70)
OmniComm is a healthcare technology company that provides web-based electronic data capture and eClinical solutions and related value-added services to pharmaceutical and biotech companies, contract research organizations, and other clinical trial sponsors.
price ($mm)[EV]
$72 [$81]
rev ($mm)
$25
EBITDA ($mm)
$2
EV / rev
3.4x
EV / EBITDA
46.2x
announced 6/12/2019 via BusinessWire

Dassault Systemes, will acquire Medidata

synopsis: Dassault Systèmes, a provider of solutions that transform the way products are designed, provided and supported, will be acquiring Medidata, a provider of a platform for clinical development, commercial, and real-world data.
buyer: Dassault Systemes (ENXTPA:DSY:$5,323.17)
Based in France, Dassault Systèmes provides clients with virtual universes to imagine sustainable innovations. Its solutions transform the way products are designed, produced, and supported. They foster social innovation, expanding possibilities for the virtual world to improve the real world. "
target: Medidata (MDSO:$660.00)
Medidata is leading the digital transformation of life science, with a platform for clinical development, commercial, and real-world data. Powered by artificial intelligence, Medidata helps accelerate value, minimize risk and optimize outcomes.
price ($mm)[EV]
$5,825 [$5,822]
rev ($mm)
$660
EBITDA ($mm)
$81
EV / rev
8.8x
EV / EBITDA
72.2x
closed 4/10/2019 via BNC Analysis

TriNetX, acquired Custodix N.V.

synopsis: TriNetX has acquired Custodix, a Belgian-based provider of clinical trial patient recruitment solutions. TriNetX is a global health research network that has revolutionised clinical research. Custodix is a provider of clinical trial patient recruitment solutions offering a range of solutions for ensuring compliance.
buyer: TriNetX
TriNetX is the global health research network enabling healthcare organizations, biopharma and CROs to collaborate, enhance trial design, accelerate recruitment and bring new therapies to market faster. "
target: Custodix N.V.
Custodix is a Belgian provider of clinical trial patient recruitment solutions offering a range of solutions for ensuring compliance with European and US data protection legislation and security best practices.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/20/2019 via Company Press Release

Civica, acquired TranSend Solutions Ltd

synopsis: Civica Group, a leader in business-critical software, digital solutions and managed services, has acquired TranSend Solutions, a UK-based company that develops supply chain proof of delivery and route planning software. TranSend provides solutions for route optimisation, electronic proof of delivery, transport compliance and delivery intelligence.
buyer parent: Partners Group Holding AG
buyer: Civica
Civica is a leading specialist in business critical software applications, digital solutions and managed services for the public sector and regulated markets. Their software and services support functions range from financial management and tax & benefits processing to medical records management "
target: TranSend Solutions Ltd
TranSend Solutions is a UK-based company that develops supply chain proof of delivery and route planning software. TranSend's web-based delivery management and monitoring systems provides solutions for route optimisation, electronic proof of delivery, transport compliance and delivery intelligence.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 10/17/2018 via Company Press Release

Oracle Corporation, will acquire GoBalto

synopsis: Oracle announced that it has entered into an agreement to acquire goBalto, which delivers leading cloud solutions to accelerate clinical trials by streamlining and automating the selection and set up of the best performing clinical research sites to conduct trials.
buyer: Oracle Corporation (ORCL:$39,766.00)
Oracle is a computer technology corporation developing and marketing computer hardware systems and enterprise software products. By eliminating complexity and simplifying IT, Oracle enables its customers to accelerate innovation and create added value for their customers. "
target: GoBalto
goBalto, Inc. is an award winning, venture backed group of industry veterans that creates simple, focused software for the global drug trial industry. Its products offer drug trial sponsors and clinical research organizations the fastest, easiest possible way to start clinical studies on the web.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/18/2018 via PR Newswire

Genstar Capital LLC, acquired CRF Health

synopsis: Genstar Capital, a leading investor in healthcare technology and services companies, is pleased to announce the acquisition of CRF Health, a global provider of eCOA and eConsent solutions for the life sciences industry. CRF Health's eSource solutions improve trial engagement by making the patient the center of the clinical trial process.
buyer: Genstar Capital LLC
Genstar Capital is a leading private equity firm that has been actively investing in high quality companies for more than 25 years. Based in San Francisco, Genstar works in partnership with its management teams to transform its portfolio companies into industry-leading businesses. "
target parent: Vitruvian Partners LLP
target: CRF Health
CRF Health is the leading provider of patient-centered eSource technology solutions for the life sciences industry. CRF Health's TrialMax® platform consistently demonstrates the industry's highest data accuracy, patient and site compliance, and patient retention.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/21/2018 via BusinessWire

Anju Software, acquired Sylogent

synopsis: Anju Software Inc., a life sciences software platform backed by Providence Equity Partners, has acquired Sylogent. Sylogent delivers cloud based state of the art software solutions and business services to the pharmaceutical industry focused specifically on the information required to bring a product to market.
buyer parent: Providence Equity Partners Inc.
buyer: Anju Software
Anju Software is a life sciences enterprise software platform focused on delivering exceptional business application solutions. Anju was founded by professionals with deep software domain expertise and a track record of building software platforms through strategic acquisitions and organic growth. "
target: Sylogent
Sylogent delivers software and business services to the pharmaceutical industry focused specifically on the information required to bring a product to market. They ensure the timely completion of critical information, maximize compliance goals and reduce risk management liability.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/24/2017 via PR Newswire

Bracket Global, acquired mProve Health

synopsis: Bracket, a leading clinical trial technology and specialty services provider, announced the strategic acquisition of mProve Health Inc., a leading provider of mobile technologies for life science companies. mProve Health offers regulatory compliant mobile solutions for patient recruitment and electronic clinical outcome assessments.
buyer parent: Genstar Capital LLC
buyer: Bracket Global
Bracket is a clinical trial technology and specialty services provider dedicated to helping biopharmaceutical sponsors and contract research organizations increase the power of their clinical research data by leveraging core competencies in Science, Technology, and Service. "
target: mProve Health
mProve Health is a leading provider of mobile technologies for life science companies, helping them connect better with patients. The company offers industry-grade, regulatory compliant mobile solutions for patient recruitment, patient engagement, and electronic clinical outcome assessments.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/9/2017 via Company Press Release

PRA Health Sciences, acquired Parallel 6

synopsis: HCAP Partners, a California-based mezzanine debt and private equity firm, announced that it has exited its investment in Parallel 6, Inc. (“P6”), a mobile clinical (“mClinical”) SaaS platform designed to recruit, enroll, engage and manage patients in clinical trials. P6 was sold to PRA Health Sciences, Inc.
buyer parent: Kohlberg Kravis Roberts & Co.
buyer: PRA Health Sciences (PRAH:$1,698.48)
PRA Health Sciences, Inc. is one of the world’s leading global CROs by revenue, providing outsourced clinical development services to the biotechnology and pharmaceutical industries. Since 2000, PRA has participated in approximately 3,500 clinical trials worldwide. "
target parent: HCAP Partners
target: Parallel 6
Parallel 6’s technology digitally enrolls, engages and manages patients using mobile endpoints. Sponsors and clinical research organizations can connect directly with and manage patients anywhere in the world, seamlessly integrating into their daily lives.
price ($mm)
$40
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/1/2017 via PR Newswire

TraceLink, Inc., acquired ROC IT Solutions

synopsis: TraceLink Inc., the World's Largest Track and Trace Network for connecting the life sciences supply chain and providing real-time information sharing for better patient outcomes, announced that it has acquired ROC IT Solutions, the leader in intelligent edge data capture for serialized product inventory in the pharmaceutical supply chain.
buyer: TraceLink, Inc.
TraceLink is the Largest Track and Trace Network for connecting the Life Sciences supply chain & eliminating counterfeit prescription drugs from the global marketplace. Their Life Sciences Cloud delivers complete connectivity, visibility & traceability of pharmaceuticals from ingredient to patient. "
target: ROC IT Solutions
ROC IT Solutions is the leader in intelligent edge data capture for serialized product inventory in the pharmaceutical supply chain. Its EdgeTrac Software Suite offers serialized receiving, picking, shipping, returns, deactivation, aggregation, label printing, and tag management of pharmaceuticals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like Clintara


read more

Clintara

Habitu Health

Forte Research Systems

OmniComm Systems, Inc.

e-novex

invivodata, Inc.

Viewics, Inc.

InferMed

Bio-Optronics Group, LLC

HealthMode

Clinical Ink

Clinical Ink

VirMedica

Statsols

RXTransparent

DoseMe

vMEDEX, Inc.

Design Clinicals

KM Medical Software

Commonwealth Informatics Inc.

read more

Clintara

read more

VirTrial

mProve Health

Bracket Global

CLINapps

Clintara

Bracket

read more

Clintara

MedSciNet

Greenphire, Inc

Pharmarack Technologies Private Limited

TrialTech Medical Inc.

BSI Business Systems Integration

TradeTicity

Viedoc

Clinical Trial Connect, LLC

THREAD Research

OmniComm Systems, Inc.

Medidata

Custodix N.V.

TranSend Solutions Ltd

GoBalto

CRF Health

Sylogent

mProve Health

Parallel 6

ROC IT Solutions

Geography
Matching Companies
Ticker: OMCL
 
 
 
 
 
 
 
 
Omnicell, Inc.
Omnicell, Inc.
Omnicell is a leading supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the entire health care continuum—from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home.
year
2020
rev ($mm)
$906.40
EBITDA ($mm)
$100.91
EBIT ($mm)
$61.95
Net Income ($mm)
$49.09
Employees
2780
  • drill down
  • watch
Ticker: TRHC
 
 
 
 
 
 
 
 
Tabula Rasa Healthcare
Tabula Rasa Healthcare
Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk.
year
2018
rev ($mm)
$204.27
EBITDA ($mm)
$16.27
EBIT ($mm)
$1.63
Net Income ($mm)
Employees
952
  • drill down
  • watch
Ticker: ZMD
 
 
 
 
 
 
 
 
ZoomMed Inc.
ZoomMed Inc.
Zoommed Inc. develops and markets various computer applications for healthcare professionals in Canada. The company builds and operates the ZoomMed Communication Network, a clinical interoperable information exchange network between physicians and various other stakeholders of the healthcare sector.
year
2014
rev ($mm)
$6.08
EBITDA ($mm)
$2.65
EBIT ($mm)
$2.78
Net Income ($mm)
Employees
40
  • drill down
  • watch
Ticker: AIM:INS
 
 
 
 
 
 
 
 
Instem
Instem
Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide.
year
2020
rev ($mm)
$38.71
EBITDA ($mm)
$6.69
EBIT ($mm)
$5.66
Net Income ($mm)
$0.47
Employees
268
  • drill down
  • watch
Ticker: CERN
 
 
 
 
 
 
 
 
Cerner Corporation
Cerner Corporation
Cerner's health information technologies connect people, information, and systems. Cerner solutions assist clinicians in making care decisions and enable organizations to manage the health of populations.
year
2020
rev ($mm)
$5,552.99
EBITDA ($mm)
$1,247.29
EBIT ($mm)
$792.06
Net Income ($mm)
$792.91
Employees
27400
  • drill down
  • watch
Ticker: 300253
 
 
 
 
 
 
 
 
Shanghai Kingstar Winning Software Co., Ltd.
Shanghai Kingstar Winning Software is principally engaged in the development of medical software, the provision of technology services and the distribution of hardware products. They primarily offer software, including hospital information systems and public health information management systems.
year
2015
rev ($mm)
$98.42
EBITDA ($mm)
$14.01
EBIT ($mm)
$12.72
Net Income ($mm)
$21.57
Employees
454
  • drill down
  • watch
Ticker: OM:RTC
 
 
 
 
 
 
 
 
Rethinking Care AB
Rethinking Care AB
Rethinking Care introduces a holistic concept in nursing & health, based on 3 interacting spheres of activity - "Software as a service", "Care as a service" & "Health as a service", based on a high level of competence in nursing & healthcare services as well as IT tools developed for health care.
year
2016
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: INOV
 
 
 
 
 
 
 
 
Inovalon, Inc.
Inovalon, Inc.
Inovalon is a leading technology company that combines advanced cloud-based data analytics and data-driven intervention platforms to achieve meaningful insight and impact in clinical and quality outcomes, utilization, and financial performance across the healthcare landscape.
year
2017
rev ($mm)
$449.36
EBITDA ($mm)
$75.91
EBIT ($mm)
$27.16
Net Income ($mm)
$34.82
Employees
2119
  • drill down
  • watch
Ticker: DATA
 
 
 
 
 
 
 
 
DATATRAK International, Inc.
DATATRAK International, Inc.
DATATRAK International, Inc. is a worldwide ASP for the EDC industry. The Company provides a suite of software products supporting the use of DATATRAK EDC(TM) and related services to the pharmaceutical, biotechnology, and medical device industries.
year
2012
rev ($mm)
$9.72
EBITDA ($mm)
($1.37)
EBIT ($mm)
($1.53)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: MDRX
 
 
 
 
 
 
 
 
Allscripts
Allscripts
Allscripts is the leading provider of clinical software, connectivity and information solutions that physicians use to improve healthcare. The company's unique solutions inform, connect and transform healthcare, delivering improved care at lower cost.
year
2020
rev ($mm)
$1,718.10
EBITDA ($mm)
$70.02
EBIT ($mm)
($3.04)
Net Income ($mm)
Employees
9600
  • drill down
  • watch
Ticker: DB:COP
 
 
 
 
 
 
 
 
CompuGroup Medical AG
CompuGroup Medical AG
CompuGroup Medical is a leading global eHealth provider. Their software and communications solutions assist doctors, dentists, hospitals, pharmacists, associations, networks and other service providers with workflow, diagnosis and therapy.
year
2021
rev ($mm)
$1,114.18
EBITDA ($mm)
$198.41
EBIT ($mm)
$139.33
Net Income ($mm)
$87.05
Employees
7534
  • drill down
  • watch
Ticker: QSII
 
 
 
 
 
 
 
 
Quality Systems, Inc.
Quality Systems, Inc.
Quality Systems, Inc. and its NextGen Healthcare subsidiary develop and market computer-based practice management, electronic health records and revenue cycle management applications as well as connectivity products and services for medical and dental group practices.
year
2015
rev ($mm)
$499.35
EBITDA ($mm)
$57.19
EBIT ($mm)
$44.23
Net Income ($mm)
$32.10
Employees
2927
  • drill down
  • watch
Ticker: AIM:EMIS
 
 
 
 
 
 
 
 
EMIS Group PLC
EMIS Group PLC
Egton Medical Information Systems Ltd (EMIS) is the UK's market leading primary care software provider with more than 39 million patient records entrusted to its systems. Its aim is to make good quality, timely patient information available any time, any where through interoperable systems.
year
2018
rev ($mm)
$216.76
EBITDA ($mm)
$33.15
EBIT ($mm)
$21.39
Net Income ($mm)
$14.24
Employees
2046
  • drill down
  • watch
Ticker: EVH
 
 
 
 
 
 
 
 
Evolent Health
Evolent Health
Evolent partners with leading health systems to drive value-based care transformation. By providing clinical, analytical and financial capabilities, Evolent helps physicians and health systems achieve superior quality and cost results.
year
2016
rev ($mm)
$212.24
EBITDA ($mm)
($39.30)
EBIT ($mm)
($52.25)
Net Income ($mm)
Employees
946
  • drill down
  • watch
Ticker: MTBC
 
 
 
 
 
 
 
 
Medical Transcription Billing, Corp.
Medical Transcription Billing, Corp.
MTBC (Medical Transcription Billing, Corp) is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers, revenue cycle management companies and software vendors.
year
2019
rev ($mm)
$65.19
EBITDA ($mm)
$1.78
EBIT ($mm)
($1.62)
Net Income ($mm)
Employees
2400
  • drill down
  • watch
Ticker: AIM:INS
 
 
 
 
 
 
 
 
Instem
Instem
Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide.
year
2020
rev ($mm)
$38.71
EBITDA ($mm)
$6.69
EBIT ($mm)
$5.66
Net Income ($mm)
$0.47
Employees
268
  • drill down
  • watch
Ticker: DATA
 
 
 
 
 
 
 
 
DATATRAK International, Inc.
DATATRAK International, Inc.
DATATRAK International, Inc. is a worldwide ASP for the EDC industry. The Company provides a suite of software products supporting the use of DATATRAK EDC(TM) and related services to the pharmaceutical, biotechnology, and medical device industries.
year
2012
rev ($mm)
$9.72
EBITDA ($mm)
($1.37)
EBIT ($mm)
($1.53)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: SLP
 
 
 
 
 
 
 
 
Simulations Plus, Inc.
Simulations Plus, Inc.
Simulations Plus, Inc. is a premier developer of groundbreaking drug discovery and development simulation and modeling software that is licensed to and used in the conduct of drug research by major pharmaceutical, biotechnology, agrochemical, and food industry companies worldwide.
year
2019
rev ($mm)
$35.84
EBITDA ($mm)
$12.38
EBIT ($mm)
$11.28
Net Income ($mm)
$9.11
Employees
109
  • drill down
  • watch
Ticker: POAI
 
 
 
 
 
 
 
 
Predictive Oncology Inc.
Predictive Oncology Inc.
Predictive Oncology Inc. is a knowledge-driven company focused on applying artificial intelligence to personalized medicine and drug discovery. Predictive Oncology operates through five segments which contain four subsidiaries; Helomics, TumorGenesis, Skyline Medical and Skyline Europe.
year
2019
rev ($mm)
$1.38
EBITDA ($mm)
($13.26)
EBIT ($mm)
($13.71)
Net Income ($mm)
Employees
24
  • drill down
  • watch
Ticker: CHNG
 
 
 
 
 
 
 
 
Change Healthcare Corporation
Change Healthcare Corporation
Change Healthcare is a leading independent healthcare technology company that provides data and analytics-driven solutions to improve clinical, financial and patient engagement outcomes in the U.S. healthcare system.
year
2020
rev ($mm)
$1,646.91
EBITDA ($mm)
EBIT ($mm)
($155.95)
Net Income ($mm)
Employees
15000
  • drill down
  • watch
Ticker: OMCL
 
 
 
 
 
 
 
 
Omnicell, Inc.
Omnicell, Inc.
Omnicell is a leading supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the entire health care continuum—from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home.
year
2020
rev ($mm)
$906.40
EBITDA ($mm)
$100.91
EBIT ($mm)
$61.95
Net Income ($mm)
$49.09
Employees
2780
  • drill down
  • watch
Ticker: TRHC
 
 
 
 
 
 
 
 
Tabula Rasa Healthcare
Tabula Rasa Healthcare
Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk.
year
2018
rev ($mm)
$204.27
EBITDA ($mm)
$16.27
EBIT ($mm)
$1.63
Net Income ($mm)
Employees
952
  • drill down
  • watch
Ticker: ZMD
 
 
 
 
 
 
 
 
ZoomMed Inc.
ZoomMed Inc.
Zoommed Inc. develops and markets various computer applications for healthcare professionals in Canada. The company builds and operates the ZoomMed Communication Network, a clinical interoperable information exchange network between physicians and various other stakeholders of the healthcare sector.
year
2014
rev ($mm)
$6.08
EBITDA ($mm)
$2.65
EBIT ($mm)
$2.78
Net Income ($mm)
Employees
40
  • drill down
  • watch
Ticker: ASX:MDR
 
 
 
 
 
 
 
 
MedAdvisor Limited
MedAdvisor Limited
MedAdvisor is a world class medication management platform focused on addressing the gap and burden of medication adherence. The highly automated Australian software system connects patients to their local pharmacy, providing them with real time access to their personal medication records.
year
2016
rev ($mm)
$1.05
EBITDA ($mm)
($2.13)
EBIT ($mm)
($2.15)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: MRCY
 
 
 
 
 
 
 
 
Mercury Computer Systems, Inc.
Mercury Computer Systems, Inc.
Mercury Computer Systems is the leading supplier of high-performance digital signal and image processing systems. These embedded computer systems transform streams of sensor data to visual information in real time for analysis and interpretation.
year
2011
rev ($mm)
$228.71
EBITDA ($mm)
$33.90
EBIT ($mm)
$25.55
Net Income ($mm)
$18.44
Employees
602
  • drill down
  • watch
Ticker: SYPT
 
 
 
 
 
 
 
 
Scrypt, Inc.
Scrypt, Inc.
Since 1998, Austin-based Scrypt, Inc. has been creating elegant document productivity tools for healthcare that eliminate manual processes and paper to save time and money. Scrypt has more than 30,000 customers across all 50 states.
year
2009
rev ($mm)
$0.27
EBITDA ($mm)
($0.85)
EBIT ($mm)
($0.91)
Net Income ($mm)
Employees
7
  • drill down
  • watch